U.S. Launches Investigation into Medical Device and PPE…
On September 26, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) announced a Section 232 investigation into …
Read more
RegASK sponsors RAPS Convergence 2025
RegASK is proud to participate in RAPS Convergence 2025, the largest annual gathering for regulatory affairs professionals, bringing togethe…
Read more
$7 Billion Parkinson’s Disease Market by 2033: Implic…
On August 5, 2025, Clinical Trials Arena released a market forecast detailing significant growth in Parkinson’s disease (PD) therapeutics …
Read more
Major U.S. Reform Bill Triggers Regulatory Consequences…
July 4, 2025 – In a move set to reshape key sectors, U.S. President Donald Trump has signed into law H.R.1 – the “One Big Beautiful Bi…
Read more
FDA Launches “Elsa”: Agency-Wide Generative…
On June 2, 2025, the U.S. Food and Drug Administration (FDA) officially launched Elsa, a generative artificial intelligence (AI) tool develo…
Read more
Powering Global Hybrid Clinical Trials: Simplified, Com…
The Challenge A leading global pharmaceutical company was preparing to scale hybrid clinical trials for its Food for Special Medical Purpose…
Read more
Breaking Into the US: Compliant Claims for an Innovativ…
The Challenge Bringing an infant formula to the U.S. market isn’t just about innovation. It’s about navigating one of the most rigorous …
Read more
Esko and RegASK Partner to Transform Packaging Complian…
ST. LOUIS & NEW YORK–(BUSINESS WIRE)–RegASK, a leading provider of AI-driven regulatory intelligence for Consumer Goods and …
Read more
MAHA Commission Releases Report on U.S. Childhood Chron…
Presidential Commission Releases Landmark Report on U.S. Childhood Chronic Disease Crisis May 22, 2025 – The Presidential Commission to Ma…
Read more
EPA Proposes Renewal of Hazardous Remediation Waste Ove…
May 23, 2025 – The U.S. Environmental Protection Agency (EPA) has proposed a renewal of its Information Collection Request (ICR) related t…
Read more